Antibacterial Resistance Leadership Group

Combining ceftazidime-avibactam and aztreonam could help tackle tough antibiotic-resistant infections. The #ARLGnetwork COMBINE studies explored the safest and most effective ways to use these drugs together. Learn more: duke.is/ARLG-COMBINE #AMR #IDTwitter

🔬The STEP FMT #ARLGnetwork study team is in writing mode! This mentee project examined how certain gut bacteria take hold after fecal microbiota transplantation – key to advancing microbiome therapeutics. Learn more about ARLG studies🔗duke.is/ARLG-milestone…

📄The #ARLGnetwork FAST study team submitted another manuscript! The study compared outcomes for patients who had rapid phenotypic antimicrobial susceptibility testing (AST) for #GramNegative bacteremia vs standard AST. Learn more about ARLG studies 🔗 duke.is/ARLG-milestone…

💡The #ARLGnetwork’s DOOR paradigm puts patients at the center by evaluating both benefits and risks together, offering a more complete view of treatment impact. Learn more about this innovative, patient-focused approach to #ClinicalResearch🔗duke.is/ARLG-pub-Hamas…

✅#ARLGnetwork DIFFR study researchers submitted a manuscript! This mentee project developed a new test for C. difficile that detects toxin mRNA in stool & compared its accuracy to gold standard methods. Learn more about ARLG studies 🔗duke.is/ARLG-milestone…

💡The #ARLGnetwork’s Drs. Angela Huttner, Tom Holland, & @davidantibiotic will join other experts in #InfectiousDiseases & #Microbiology in leading a 3-day @ESCMID postgrad course to train new researchers in all phases of clinical trials🔗duke.is/ARLG-ESCMID-co…

🔍Innovative tests to quickly identify bacterial infections can save lives by helping doctors choose the best treatments for their patients. In this commentary, #ARLGnetwork members describe how new tests can be evaluated to ensure results are reliable🔗duke.is/ARLG-pub-Doern…

The @ARLGNetwork recently had two studies featured in a late-breaking session at #ESCMID2026— highlighting global collaboration and evidence to fight antibiotic resistance. Learn more: duke.is/9/xp9w

Heather Cross has been with the #ARLGnetwork since its inception in 2013. She oversees all ARLG operations, supports early career clinicians & leads talented teams conducting clinical trials to improve treatments for patients with bacterial infections🔗duke.is/arlg-hrc

📊Study Milestone: The #ARLGnetwork ESCAPED study is analyzing data! This mentee project aimed to describe the S. aureus #AMR patterns, risk factors, & antibiotic prescribing practices for patients in emergency departments. Learn more: duke.is/ARLG-milestone…

DYK the #ARLGnetwork maintains a biorepository of bacteria for the #AMR community? 24 ARLG Klebsiella pneumoniae isolates were used in a research project to identify phages that could offer alternative treatment options for multi-drug resistant infections🔗duke.is/ARLG-pub-Cuello

🎥ICYMI: Learn about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection in this recording of the #ARLGnetwork Grand Rounds, “The Why & How of the ACORN Trial,” presented by @EdQian & @toddrice_ICU, @VUMCDiscoveries: duke.is/ARLG-GR-ACORN

🎉Congratulations to @lodise_tom, #ARLGnetwork’s Pharmacokinetic Lead, who received the @ASHPFoundation 2025 Literature Award for Sustained Contributions! Read about his impactful work to improve care for patients with #AMR infections: duke.is/ARLG-Lodise-AS…

Robin Patel, ARLG Lab Center Director, has been with the #ARLGnetwork since its inception in 2013. She’s committed to improving diagnostic techniques for #InfectiousDiseases & training the next generation of researchers in #AMR to advance patient care🔗duke.is/ARLG-RP

The #ARLGnetwork will have a strong presence at #ESCMIDGlobal2026! We’re excited to join 16K doctors, researchers, & innovators in infectious diseases & clinical microbiology to share our expertise in #AMR. See a list of ARLG member presentations @ESCMID🔗duke.is/ARLG-ESCMID-20…

📄The #ARLGnetwork’s FAST study compared patient outcomes with standard antimicrobial susceptibility testing (AST) versus rapid phenotypic AST for #GramNegative bacteremia. Read the publication🔗duke.is/ARLG-pub-Baner…

📰Following a report from @WHO that found increasing risk of drug-resistant superbugs, the #ARLGnetwork’s Drs. Vance Fowler and Helen Boucher shared with @AAMCtoday their insights and strategies to combat the global #AMR health crisis. Learn more: duke.is/ARLG-AAMC-news

Will you be at #ESCMIDGlobal2026 in Munich, Germany from April 17-21? Check out the list of #ARLGnetwork members who are presenting and co-chairing events at the internationally renowned event in #InfectiousDisease🔗duke.is/ARLG-ESCMID-20… We hope to see you @ESCMID!

📊Study Milestone: The #ARLGnetwork Pneumonia Direct Pilot (PDP) study to improve diagnostics for ventilator-associated #pneumonia has reached the data analysis phase! Learn more about PDP and other ARLG studies: duke.is/ARLG-milestone… #IDTwitter

📢The #ARLGnetwork March 2026 newsletter is now available on our website! Check out the new ARLG member spotlights, clinical site spotlight, recent publications, and more network news: duke.is/ARLG-March-2026 #AMR #IDTwitter